|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.610 0.000 (0.000%) | 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Turnover | 30,344 | -6.125% | 32,324 | 42,022 | 33,414 | 20,865 |
| Cost of Sales | (23,233) | 0.798% | (23,049) | (32,304) | (24,130) | (12,614) |
| Gross Profit | 7,111 | -23.332% | 9,275 | 9,718 | 9,284 | 8,251 |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (864) | -94.977% | (17,201) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (1) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (16,485) | -40.048% | (27,497) | (4,702) | (2,539) | (1,398) | |
| Taxation | (56) | 124.000% | (25) | (82) | (438) | (1,035) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,481 | -- | (89) | (423) | (1,022) | (170) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (15,060) | -45.457% | (27,611) | (5,207) | (3,999) | (2,603) | |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Net Finance Costs / (Income) | (99) | -- | 795 | 162 | (3,175) | (3,442) |
| Depreciation & Amortisation | 1,740 | -33.051% | 2,599 | 2,504 | 2,026 | 1,041 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| EPS (cts) | -3.190 | -51.740% | -6.610 | -1.260 | -1.000 | -0.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.157 | -- | 0.131 | 0.199 | 0.230831 | 0.297038 |
| Remarks: | Real time quote last updated: 20/11/2024 14:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -40,187,000 |
| %Change | -4.421% |
| EPS / (LPS) | HKD -0.085 |
| NBV Per Share ($) | HKD 0.109 |